FDA’s Drug Safety Office Reorganizing To Accommodate Influx Of PDUFA Staff

FDA's Office of Surveillance and Epidemiology continues changing to strengthen its drug safety operations by reorganizing prior to increasing staff by 50 percent to undertake new regulatory authorities